Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.62
+0.10 (1.81%)
At close: Oct 24, 2025, 4:00 PM EDT
5.77
+0.15 (2.67%)
After-hours: Oct 24, 2025, 6:46 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $437.62 million as of October 24, 2025. Its market cap has increased by 64.09% in one year.
Market Cap
437.62M
Enterprise Value
192.57M
1-Year Change
64.09%
Ranking
Category
Stock Price
$5.62
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $437.62M, a decrease of -94.01%. That is a compound annual growth rate of -30.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 437.62M | 173.83% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |